Rizal Aminuddin

Multiple Sclerosis Society of Malaysia (MSSM), No 31-1 Jalan SP 5/3, Bandar Saujana Putra, 42610 Selangor, Malaysia

Development of an Updated National Protocol for the Use of Disease-Modifying Treatments in Multiple Sclerosis: A MOH-MOE Steering Committee Initiative in Malaysia

    DOI: 10.52494/maljpharmv11106
    by Shridevi Subramaniam, Shanthi Viswanathan, Suhailah Abdullah, Hui-Jan Tan, Rabani Remli, Norzaini Rose Mohd Zain, Kok-Yoon Chee, Sanihah Abdul Halim, Sin-Hong Chew, Shin-Yee Chey, Hairuddin Achmad, Shalini Bhaskar, Mohd Sufian Adenan, Wan Aliaa Wan Sulaiman, Masita Arip, Ai-Leen Tan, Farah Waheeda Tajurudin, Shelina Oli Mohamed, Su-Yin Lim and Rizal Aminuddin.
    Vol. 11 No. 1 (2025): Malaysian Journal of Pharmacy / Published: June 30, 2025
    Abstract / Full Text / Download PDF

    Abstract

    Background: There has been an increase in the number of disease-modifying treatments (DMTs) for Multiple Sclerosis (MS). However, treatment accessibility, selection, monitoring, and patient-specific considerations… Read More »Development of an Updated National Protocol for the Use of Disease-Modifying Treatments in Multiple Sclerosis: A MOH-MOE Steering Committee Initiative in Malaysia